Cargando…

Nutrition, IBD and Gut Microbiota: A Review

Inflammatory bowel disease (IBD) is a chronic relapsing–remitting systemic disease of the gastrointestinal tract, characterized by an inflammatory process that requires lifelong treatment. The underlying causes of IBD are still unclear, as this heterogeneous disorder results from a complex interplay...

Descripción completa

Detalles Bibliográficos
Autores principales: Mentella, Maria Chiara, Scaldaferri, Franco, Pizzoferrato, Marco, Gasbarrini, Antonio, Miggiano, Giacinto Abele Donato
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230231/
https://www.ncbi.nlm.nih.gov/pubmed/32235316
http://dx.doi.org/10.3390/nu12040944
_version_ 1783534901394407424
author Mentella, Maria Chiara
Scaldaferri, Franco
Pizzoferrato, Marco
Gasbarrini, Antonio
Miggiano, Giacinto Abele Donato
author_facet Mentella, Maria Chiara
Scaldaferri, Franco
Pizzoferrato, Marco
Gasbarrini, Antonio
Miggiano, Giacinto Abele Donato
author_sort Mentella, Maria Chiara
collection PubMed
description Inflammatory bowel disease (IBD) is a chronic relapsing–remitting systemic disease of the gastrointestinal tract, characterized by an inflammatory process that requires lifelong treatment. The underlying causes of IBD are still unclear, as this heterogeneous disorder results from a complex interplay between genetic variability, the host immune system and environmental factors. The current knowledge recognizes diet as a risk factor for the development of IBD and attributes a substantial pathogenic role to the intestinal dysbiosis inducing an aberrant mucosal immune response in genetically predisposed individuals. This review focused on the clinical evidence available that considers the impact of some nutrients on IBD onset and the role of different diets in the management of IBD and their effects on the gut microbiota composition. The effects of the Specific Carbohydrate Diet, low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet, gluten free diet, anti-inflammatory diet and Mediterranean diet are investigated with regard to their impact on microbiota and on the evolution of the disease. At present, no clear indications toward a specific diet are available but the assessment of dysbiosis prior to the recommendation of a specific diet should become a standard clinical approach in order to achieve a personalized therapy.
format Online
Article
Text
id pubmed-7230231
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-72302312020-05-28 Nutrition, IBD and Gut Microbiota: A Review Mentella, Maria Chiara Scaldaferri, Franco Pizzoferrato, Marco Gasbarrini, Antonio Miggiano, Giacinto Abele Donato Nutrients Review Inflammatory bowel disease (IBD) is a chronic relapsing–remitting systemic disease of the gastrointestinal tract, characterized by an inflammatory process that requires lifelong treatment. The underlying causes of IBD are still unclear, as this heterogeneous disorder results from a complex interplay between genetic variability, the host immune system and environmental factors. The current knowledge recognizes diet as a risk factor for the development of IBD and attributes a substantial pathogenic role to the intestinal dysbiosis inducing an aberrant mucosal immune response in genetically predisposed individuals. This review focused on the clinical evidence available that considers the impact of some nutrients on IBD onset and the role of different diets in the management of IBD and their effects on the gut microbiota composition. The effects of the Specific Carbohydrate Diet, low fermentable oligosaccharides, disaccharides, monosaccharides and polyols (FODMAP) diet, gluten free diet, anti-inflammatory diet and Mediterranean diet are investigated with regard to their impact on microbiota and on the evolution of the disease. At present, no clear indications toward a specific diet are available but the assessment of dysbiosis prior to the recommendation of a specific diet should become a standard clinical approach in order to achieve a personalized therapy. MDPI 2020-03-29 /pmc/articles/PMC7230231/ /pubmed/32235316 http://dx.doi.org/10.3390/nu12040944 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Mentella, Maria Chiara
Scaldaferri, Franco
Pizzoferrato, Marco
Gasbarrini, Antonio
Miggiano, Giacinto Abele Donato
Nutrition, IBD and Gut Microbiota: A Review
title Nutrition, IBD and Gut Microbiota: A Review
title_full Nutrition, IBD and Gut Microbiota: A Review
title_fullStr Nutrition, IBD and Gut Microbiota: A Review
title_full_unstemmed Nutrition, IBD and Gut Microbiota: A Review
title_short Nutrition, IBD and Gut Microbiota: A Review
title_sort nutrition, ibd and gut microbiota: a review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230231/
https://www.ncbi.nlm.nih.gov/pubmed/32235316
http://dx.doi.org/10.3390/nu12040944
work_keys_str_mv AT mentellamariachiara nutritionibdandgutmicrobiotaareview
AT scaldaferrifranco nutritionibdandgutmicrobiotaareview
AT pizzoferratomarco nutritionibdandgutmicrobiotaareview
AT gasbarriniantonio nutritionibdandgutmicrobiotaareview
AT miggianogiacintoabeledonato nutritionibdandgutmicrobiotaareview